A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups

Proteomics

Volumn 15, Issue 12, 2015, Pages 2038-2050

  Jang, Moon Kyoo ^a   Anderson, D Eric ^b   van Doorslaer, Koenraad ^a   Mcbride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

BRD4; E2; HPV; Microbiology; Papillomavirus; Virus

Indexed keywords

HOST FACTOR; NUCLEOPHOSMIN; PROTEIN SERINE KINASE; PROTEIN SRPK1; PROTEIN SRPK2; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; DNA BINDING PROTEIN; ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 1; ONCOPROTEIN; PROTEOME; VIRAL PROTEIN;

ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; HUMAN PAPILLOMAVIRUS TYPE 16; LIFE CYCLE; MASS SPECTROMETRY; NONHUMAN; PAPILLOMAVIRIDAE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEOMICS; RNA PROCESSING; SPLICEOSOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL CULTURE; CLASSIFICATION; COMPARATIVE STUDY; FIBROBLAST; HUMAN; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; METABOLISM; PHYSIOLOGY; PROCEDURES; TANDEM MASS SPECTROMETRY; VIROLOGY; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

BLOTTING, WESTERN; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; DNA-BINDING PROTEINS; FIBROBLASTS; HUMANS; IMMUNOPRECIPITATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; VIRAL PROTEINS;

EID: 84931011656     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400613     Document Type: Article

References (63)

1. Crow, J. M., HPV: the global burden. Nature 2012, 488, S2-S3.
2. Doorbar, J., Quint, W., Banks, L., Bravo, I. G. et al., The biology and life-cycle of human papillomaviruses. Vaccine 2012, 30(Suppl 5), F55-F70.
3. McBride, A. A., The papillomavirus E2 proteins. Virology 2013, 445, 57-79.
4. Jang, M. K., Kwon, D., McBride, A. A., Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J. Virol. 2009, 83, 2592-2600.
5. Jang, M. K., Shen, K., McBride, A. A., Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome. PLoS Pathog. 2014, 10, e1004117.
6. Lai, M. C., Teh, B. H., Tarn, W. Y., A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J. Biol. Chem. 1999, 274, 11832-11841.
7. Van Doorslaer, K., Tan, Q., Xirasagar, S., Bandaru, S. et al., The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 2013, 41, D571-D578.
8. Gauthier, J. M., Dillner, J., Yaniv, M., Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains. Nucleic Acids Res. 1991, 19, 7073-7079.
9. Sekhar, V., Reed, S. C., McBride, A. A., Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes. J. Virol. 2010, 84, 543-557.
10. Poddar, A., Reed, S. C., McPhillips, M. G., Spindler, J. E., McBride, A. A., The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. J. Virol. 2009, 83, 640-650.
11. Sekhar, V., McBride, A. A., Phosphorylation regulates binding of the human papillomavirus type 8 E2 protein to host chromosomes. J. Virol. 2012, 86, 10047-10058.
12. Oliveira, J. G., Colf, L. A., McBride, A. A., Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. USA 2006, 103, 1047-1052.
13. McPhillips, M. G., Ozato, K., McBride, A. A., Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 2005, 79, 8920-8932.
14. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M. et al., A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 1999, 17, 1030-1032.
15. Ogawa, H., Ishiguro, K.-I., Gaubatz, S., Livingston, D. M., Nakatani, Y., A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 2002, 296, 1132-1136.
16. Penrose, K. J., McBride, A. A., Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 2000, 74, 6031-6038.
17. Antson, A. A., Burns, J. E., Moroz, O. V., Scott, D. J. et al., Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 2000, 403, 805-809.
18. Hegde, R. S., Androphy, E. J., Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J. Mol. Biol. 1998, 284, 1479-1489.
19. Dignam, J. D., Lebovitz, R. M., Roeder, R. G., Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983, 11, 1475-1489.
20. McPhillips, M. G., Oliveira, J. G., Spindler, J. E., Mitra, R., McBride, A. A., Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 2006, 80, 9530-9543.
21. Skiadopoulos, M. H., McBride, A. A., Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J. Virol. 1998, 72, 2079-2088.
22. Bodaghi, S., Jia, R., Zheng, Z. M., Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites. Virology 2009, 386, 32-43.
23. You, J., Croyle, J. L., Nishimura, A., Ozato, K., Howley, P. M., Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 2004, 117, 349-360.
24. Baxter, M. K., McPhillips, M. G., Ozato, K., McBride, A. A., The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 2005, 79, 4806-4818.
25. Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A. et al., The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 2011, 31, 2641-2652.
26. Maruyama, T., Farina, A., Dey, A., Cheong, J. et al., A mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase. Mol.Cell. Biol. 2002, 22, 6509-6520.
27. Sarai, N., Nimura, K., Tamura, T., Kanno, T. et al., WHSC1 links transcription elongation to HIRA-mediated histone H3. 3 deposition. EMBO J. 2013, 32, 2392-2406.
28. Yan, J., Li, Q., Lievens, S., Tavernier, J., You, J., Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. J. Virol. 2010, 84, 76-87.
29. Terhune, S. S., Moorman, N. J., Cristea, I. M., Savaryn, J. P. et al., Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. PLoS Pathog. 2010, 6, e1000965.
30. Smith, J. A., Haberstroh, F. S., White, E. A., Livingston, D. M. et al., SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter. Virology 2014, 468, 311-321.
31. Murray, J. M., Carr, A. M., Smc5/6: a link between DNA repair and unidirectional replication? Nat. Rev. Mol. Cell. Biol. 2008, 9, 177-182.
32. Kegel, A., Sjogren, C., The Smc5/6 complex: more than repair? Cold Spring Harb. Symp. Quant. Biol. 2010, 75, 179-187.
33. Wu, S. Y., Lee, A. Y., Hou, S. Y., Kemper, J. K. et al., Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 2006, 20, 2383-2396.
34. Malik-Soni, N., Frappier, L., Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. J. Virol. 2012, 86, 6999-7002.
35. Krainer, A. R., Mayeda, A., Kozak, D., Binns, G., Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 1991, 66, 383-394.
36. Petersen-Mahrt, S. K., Estmer, C., Öhrmalm, C., Matthews, D. A. et al., The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 1999, 18, 1014-1024.
37. Ito, S., Ikeda, M., Kato, N., Matsumoto, A. et al., Epstein-Barr virus nuclear antigen-1 binds to nuclear transporter karyopherin α1/NPI-1 in addition to karyopherin α2/Rch1. Virology 2000, 266, 110-119.
38. Matthews, D., Russell, W., Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J. Gen. Virol. 1998, 79, 1677-1685.
39. Chen, M.-R., Yang, J.-F., Wu, C.-W., Middeldorp, J. M., Chen, J.-Y., Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin. J. Biomed. Sci. 1998, 5, 173-179.
40. Bryant, H. E., Matthews, D. A., Wadd, S., Scott, J. E. et al., Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32. J. Virol. 2000, 74, 11322-11328.
41. Ghebrehiwet, B., Lim, B. L., Peerschke, E. I., Willis, A. C., Reid, K. B., Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular heads of C1q. J. Exp. Med. 1994, 179, 1809-1821.
42. Soltys, B. J., Kang, D., Gupta, R. S., Localization of P32 protein (gC1q-R) in mitochondria and at specific extramitochondrial locations in normal tissues. Histochem. Cell Biol. 2000, 114, 245-255.
43. Dutta, S., Akey, I. V., Dingwall, C., Hartman, K. L. et al., The crystal structure of nucleoplasmin-core: implications for histone binding and nucleosome assembly. Mol. Cell 2001, 8, 841-853.
44. Muller, M., Jacob, Y., Jones, L., Weiss, A. et al., Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions. PLoS Pathog. 2012, 8, e1002761.
45. Rehtanz, M., Schmidt, H. M., Warthorst, U., Steger, G., Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription. Mol. Cell. Biol. 2004, 24, 2153-2168.
46. Muller, M., Demeret, C., The HPV E2-host protein-protein interactions: a complex hijacking of the cellular network. Open Virol. J. 2012, 6, 173-189.
47. Emelyanov, A. V., Rabbani, J., Mehta, M., Vershilova, E. et al., Drosophila TAP/p32 is a core histone chaperone that cooperates with NAP-1, NLP, and nucleophosmin in sperm chromatin remodeling during fertilization. Genes Dev. 2014, 28, 2027-2040.
48. Chen, G. I., Gingras, A. C., Affinity-purification mass spectrometry (AP-MS) of serine/threonine phosphatases. Methods 2007, 42, 298-305.
49. Samad, M. A., Okuwaki, M., Haruki, H., Nagata, K., Physical and functional interaction between a nucleolar protein nucleophosmin/B23 and adenovirus basic core proteins. FEBS Lett. 2007, 581, 3283-3288.
50. Malik-Soni, N., Frappier, L., Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein. J. Virol. 2014, 88, 2323-2326.
51. Ulrich, H. D., New insights into replication clamp unloading. J. Mol. Biol. 2013, 425, 4727-4732.
52. Xiao, A., Li, H., Shechter, D., Ahn, S. H. et al., WSTF regulates the H2A. X DNA damage response via a novel tyrosine kinase activity. Nature 2008, 457, 57-62.
53. Bozhenok, L., Wade, P. A., Varga-Weisz, P., WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci. EMBO J. 2002, 21, 2231-2241.
54. Gui, J. F., Tronchere, H., Chandler, S. D., Fu, X. D., Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc. Natl. Acad. Sci. USA 1994, 91, 10824-10828.
55. Wang, W. S., Lee, M. S., Tseng, C. E., Liao, I. H. et al., Interaction between human papillomavirus type 5 E2 and polo-like kinase 1. J. Med. Virol. 2009, 81, 536-544.
56. Prescott, E. L., Brimacombe, C. L., Hartley, M., Bell, I. et al., Human papillomavirus type 1 E1^ E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2. J. Virol. 2014, 88, 12599-12611.
57. McBride, A. A., Bolen, J. B., Howley, P. M., Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. J.Virol. 1989, 63, 5076-5085.
58. Penrose, K. J., Garcia-Alai, M., Prat-Gay, G., McBride, A. A., CK2 phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein. J. Biol.Chem. 2004, 279, 22430-22439.
59. Shire, K., Kapoor, P., Jiang, K., Hing, M. N. et al., Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation. J. Virol. 2006, 80, 5261-5272.
60. Thandapani, P., O'Connor, T. R., Bailey, T. L., Richard, S., Defining the RGG/RG motif. Mol. Cell 2013, 50, 613-623.
61. Hisaoka, M., Ueshima, S., Murano, K., Nagata, K., Okuwaki, M., Regulation of nucleolar chromatin by B23/nucleophosmin jointly depends upon its RNA binding activity and transcription factor UBF. Mol. Cell. Biol. 2010, 30, 4952-4964.
62. Nilsen, T. W., The spliceosome: the most complex macromolecular machine in the cell? Bioessays 2003, 25, 1147-1149.
63. Sakakibara, N., Chen, D., Jang, M. K., Kang, D. W. et al., Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA. PLoS Pathog. 2013, 9, e1003777.